日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix(®) Tetra, a Seasonal Hemagglutinin-Based Vaccine

OVX836(一种基于核蛋白的通用流感疫苗)与 Fluarix® Tetra(一种基于季节性血凝素的疫苗)联合接种的安全性和免疫原性

Groth, Nicola; Bruhwyler, Jacques; Tourneur, Jessika; Piat, Emilie; Moris, Philippe; Le Vert, Alexandre; Nicolas, Florence

Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults

OVX836(一种基于核蛋白的通用流感疫苗)在老年人群中的安全性、免疫原性和交叉反应免疫的评估

Jacobs, Bart; Leroux-Roels, Isabel; Bruhwyler, Jacques; Groth, Nicola; Waerlop, Gwenn; Janssens, Yorick; Tourneur, Jessika; De Boever, Fien; Alhatemi, Azhar; Moris, Philippe; Le Vert, Alexandre; Leroux-Roels, Geert; Nicolas, Florence

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age

ChAd155载体呼吸道合胞病毒(RSV)疫苗在12-23个月龄健康RSV血清阳性儿童中的安全性和免疫原性

Díez-Domingo, Javier; Sáez-Llorens, Xavier; Rodriguez-Weber, Miguel A; Epalza, Cristina; Chatterjee, Archana; Chiu, Cheng-Hsun; Lin, Chien-Yu; Berry, Andrea A; Martinón-Torres, Federico; Baquero-Artigao, Fernando; Langley, Joanne M; Ramos Amador, José T; Domachowske, Joseph B; Huang, Li-Min; Chiu, Nan-Chang; Esposito, Susanna; Moris, Philippe; Lien-Anh Nguyen, Thi; Nikic, Vanja; Woo, Wayne; Zhou, Yingjun; Dieussaert, Ilse; Leach, Amanda; Gonzalez Lopez, Antonio; Vanhoutte, Nicolas

First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults

首次人体随机研究,旨在评估基于黑猩猩腺病毒-155病毒载体的呼吸道合胞病毒(RSV)研究疫苗在健康成年人中的安全性和免疫原性,该疫苗表达RSV融合蛋白、核衣壳蛋白和抗终止蛋白。

Cicconi, Paola; Jones, Claire; Sarkar, Esha; Silva-Reyes, Laura; Klenerman, Paul; de Lara, Catherine; Hutchings, Claire; Moris, Philippe; Janssens, Michel; Fissette, Laurence A; Picciolato, Marta; Leach, Amanda; Gonzalez-Lopez, Antonio; Dieussaert, Ilse; Snape, Matthew D

Safety and Immunogenicity of an AS03(B)-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study

一项针对健康美国成年人的1/2期随机研究:采用不同接种方案接种AS03(B)佐剂灭活四价登革病毒疫苗的安全性和免疫原性

Lin, Leyi; Lyke, Kirsten E; Koren, Michael; Jarman, Richard G; Eckels, Kenneth H; Lepine, Edith; McArthur, Monica A; Currier, Jeffrey R; Friberg, Heather; Moris, Philippe; Keiser, Paul B; De La Barrera, Rafael; Vaughn, David W; Paris, Robert M; Thomas, Stephen J; Schmidt, Alexander C

Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine

AS04佐剂人HPV-16/18疫苗2剂或3剂接种方案后,对非疫苗人乳头瘤病毒31型和45型的长期交叉反应性

Folschweiller, Nicolas; Behre, Ulrich; Dionne, Marc; Durando, Paolo; Esposito, Susanna; Ferguson, Linda; Ferguson, Murdo; Hillemanns, Peter; McNeil, Shelly A; Peters, Klaus; Ramjattan, Brian; Schwarz, Tino F; Supparatpinyo, Khuanchai; Suryakirian, Pemmaraju V; Janssens, Michel; Moris, Philippe; Decreux, Annabelle; Poncelet, Sylviane; Struyf, Frank

Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions

在登革热流行区和非流行区居民中,针对不同配方的减毒活四价登革热候选疫苗的细胞介导免疫反应

Moris, Philippe; Bauer, Kristen M; Currier, Jeffrey R; Friberg, Heather; Eckels, Kenneth H; Esquilin, Ines O; Gibbons, Robert V; Innis, Bruce L; Jarman, Richard G; Simasathien, Sriluck; Sun, Peifang; Thomas, Stephen J; Watanaveeradej, Veerachai

Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine

候选RTS,S疟疾疫苗临床试验中T细胞免疫反应的特征分析

Moris, Philippe; Jongert, Erik; van der Most, Robbert G

Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children

四价减毒活登革热疫苗的长期安全性和免疫原性以及对健康泰国儿童接种加强针的评估

Watanaveeradej, Veerachai; Simasathien, Sriluck; Mammen, Mammen P; Nisalak, Ananda; Tournay, Elodie; Kerdpanich, Phirangkul; Samakoses, Rudiwilai; Putnak, Robert J; Gibbons, Robert V; Yoon, In-Kyu; Jarman, Richard G; De La Barrera, Rafael; Moris, Philippe; Eckels, Kenneth H; Thomas, Stephen J; Innis, Bruce L

Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination

一项针对3至9岁儿童的AS03佐剂H5N1流感大流行前疫苗的II期随机、开放、对照研究:接种后24个月的安全性和免疫原性持久性随访

Díez-Domingo, Javier; Baldó, José-María; Planelles-Catarino, Maria Victoria; Garcés-Sánchez, María; Ubeda, Isabel; Jubert-Rosich, Angels; Marès, Josep; Garcia-Corbeira, Pilar; Moris, Philippe; Teko, Maurice; Vanden Abeele, Carline; Gillard, Paul